These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Combined treatment of gastric ulcers induced by nonsteroid antiinflammatory drugs. Results of 4-week population-based controlled trial of efficacy of proton pump inhibitor combination with tripotassium bismuth dicitrate]. Karateev AE; Uspenskiĭ IuP; Pakhomova IG; Nasonov EL Ter Arkh; 2009; 81(6):62-7. PubMed ID: 19663196 [TBL] [Abstract][Full Text] [Related]
26. Omeprazole or misoprostol. Which works best for NSAID-induced ulcers? Gautam M; Por CP; Evans MF Can Fam Physician; 1998 Aug; 44():1629-31. PubMed ID: 9721418 [No Abstract] [Full Text] [Related]
27. Therapy for ulcers and erosions associated with nonsteroidal anti-inflammatory drugs. Freeman HJ Can J Gastroenterol; 1998; 12(8):537-9. PubMed ID: 10206732 [No Abstract] [Full Text] [Related]
28. [Prevention and therapy of NSAID-induced ulcers: fact versus myth]. Fried M; Bertschinger P Schweiz Med Wochenschr; 1996 Sep; 126(37):1569-72. PubMed ID: 8927961 [TBL] [Abstract][Full Text] [Related]
29. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy. Scheiman JM Am J Manag Care; 2001 Feb; 7(1 Suppl):S10-4. PubMed ID: 11225347 [TBL] [Abstract][Full Text] [Related]
30. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms. Laine L Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512 [TBL] [Abstract][Full Text] [Related]
31. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate. Lazzaroni M; Sainaghi M; Bianchi Porro G Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S48-53. PubMed ID: 10379470 [TBL] [Abstract][Full Text] [Related]
32. [Recurrence of gastropathies caused by intake of nonsteroidal anti-inflammatory drugs]. Karameev AE Ter Arkh; 2003; 75(5):74-8. PubMed ID: 12847904 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of peptic ulcer related to rheumatic diseases]. Imaeda H; Ishii H; Goto M Nihon Rinsho; 2002 Aug; 60(8):1585-91. PubMed ID: 12187755 [TBL] [Abstract][Full Text] [Related]
34. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy. Cibere J; Sibley JT; Haga M J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854 [TBL] [Abstract][Full Text] [Related]
35. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection]. MMW Fortschr Med; 2004 May; 146(22):48. PubMed ID: 15373113 [No Abstract] [Full Text] [Related]
36. [Comparative efficacy of different therapeutic schemes in gastropathies induced by nonsteroid anti-inflammatory drugs]. Maev IV; V'iuchnova ES; Staseva IV Ter Arkh; 2004; 76(2):27-30. PubMed ID: 15106410 [TBL] [Abstract][Full Text] [Related]
37. [Cost effectiveness of misoprostol therapy in prevention of NSAID-induced stomach ulcers]. Schwarz B Wien Klin Wochenschr; 1995; 107(12):366-72. PubMed ID: 7631507 [TBL] [Abstract][Full Text] [Related]
38. [Evaluation of misoprostol's clinical utility for gastric/duodenal ulcers seen under long-term use of non-steroidal anti-inflammatory drugs (NSAID)--II. Evaluation of therapeutic effects on ulcers under continuous use of NSAID]. Shiokawa Y; Nobunaga M; Saito T; Sakita T; Miwa T; Nakamura K; Gunji A; Aoki K Ryumachi; 1991 Oct; 31(5):572-82. PubMed ID: 1767350 [No Abstract] [Full Text] [Related]
39. Prophylaxis and treatment of NSAID-induced gastropathy. Ament PW; Childers RS Am Fam Physician; 1997 Mar; 55(4):1323-6, 1331-2. PubMed ID: 9092293 [TBL] [Abstract][Full Text] [Related]
40. The treatment and prophylaxis of nonsteroidal anti-inflammatory drug (NSAID)-associated ulcers and erosions. Hawkey CJ; Yeomans ND Can J Gastroenterol; 1999 May; 13(4):291, 295. PubMed ID: 10400490 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]